Author:
Ruperez Maria,Shanaube Kwame,Mureithi Linda,Wapamesa Chali,Burnett James M,Kosloff Barry,de Haas Petra,Hayes Richard,Fidler Sarah,Gachie Thomas,Schaap Albertus,Floyd Sian,Klinkenberg Eveline,Ayles Helen,Africa Algernon,Amofa-Skeyi Modupe,Bond Virginia,Cheeba Maina,Dodd Pete,Kalisvaart Nico,Kangololo Bxyn,Kasese Nkatya,Mainga Tila,Mwinga Alwyn,Nikolayevskyy Vladyslav,Nyondo Beatrice,Paulsen Robynn,Simwinga Musonda,Sisam Carmen,Telisinghe Lily,Thomas Ranjeeta,Vermaak Redwaan,Vijn Frank
Funder
European and Developing Countries Clinical Trials Partnership
Reference33 articles.
1. WHO global lists of high burden countries for tuberculosis (TB), TB/HIV and multidrug/rifampicin-resistant TB (MDR/RR-TB), 2021–2025,2021
2. Implementing the end TB strategy: the essentials, 2022 update,2022
3. Does tuberculosis screening improve individual outcomes? A systematic review;Telisinghe;EClinicalMedicine,2021
4. Community-based active case-finding interventions for tuberculosis: a systematic review;Burke;Lancet Public Health,2021
5. WHO consolidated guidelines on tuberculosis module 2: systematic screening for tuberculosis disease,2021